Dupilumab Subcutaneous and Inotuzumab ozogamicin Intravenous
Determining the interaction of Dupilumab Subcutaneous and Inotuzumab ozogamicin Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dupilumab
Brand name: Dupixent
Synonyms: Dupilumab
Generic Name: inotuzumab ozogamicin
Brand name: Besponsa
Synonyms: Inotuzumab ozogamicin, Inotuzumab Ozogamicin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dupilumab Subcutaneous-Inova
- Dupilumab Subcutaneous-Inova 4/1 topical
- Dupilumab Subcutaneous-Inova 8/2 topical
- Dupilumab Subcutaneous-Inova ACT
- Dupilumab Subcutaneous-Inrebic
- Dupilumab Subcutaneous-Inspra
- Inotuzumab ozogamicin Intravenous-Dupixent
- Inotuzumab ozogamicin Intravenous-Duplex T Topical
- Inotuzumab ozogamicin Intravenous-Durachol
- Inotuzumab ozogamicin Intravenous-Duraclon
- Inotuzumab ozogamicin Intravenous-Duraclon injection
- Inotuzumab ozogamicin Intravenous-Duraflu